Levonorgestrel Intrauterine Device: Use and Precautions
Levonorgestrel IUD guidance for long-acting contraception and functional uterine bleeding, including insertion timing and major precautions.
Also searched as
Source reviewed
October 2021
Guide category
Drugs for external use and antiseptics
Safety boundary
Prescription medicine information for clinician-guided use.
Kenza Health Hub presents this medicine page as structured health education. Check dose, route, interactions, pregnancy or breast-feeding considerations, and local protocol with a qualified clinician or pharmacist. Read our medical editorial policy.
Therapeutic action
Hormonal contraceptive, progestogen.
Indications
- Long-acting contraception.
- Long-term treatment of functional uterine bleeding.
Forms and strengths
Intrauterine device (IUD) containing 52 mg of levonorgestrel and releasing 20 micrograms daily on insertion.
Dose
- The IUD may be inserted at any moment of the cycle if it is reasonably certain the woman is not pregnant, including when switching from another form of contraception.
- For contraception, use condoms for 7 days after the insertion of the IUD if it is inserted over 7 days after the start of menstrual period, over 28 days postpartum if not breastfeeding, or over 7 days after an abortion.
Duration
- Contraception: as long as this method of contraception is desired and well tolerated, for max. 5 years, after which the IUD must be changed.
- Long-term treatment of functional uterine bleeding: according to clinical response.
Contra-indications, adverse effects, precautions
- Do not use in patients with breast cancer, cervical cancer, severe or recent hepatic disease, genital infection, active thromboembolic disorders, hydatidiform mole, or other gestational trophoblastic disease.
- May cause changes in bleeding patterns such as amenorrhoea or irregular lighter bleeding; rarely heavy prolonged bleeding; abdominal pain, headache, nausea, breast tenderness, acne, weight gain, and mood change.
- IUD insertion-related complications include expulsion of IUD, pelvic infection, and risk of uterine perforation during insertion.
- The contraceptive efficacy of levonorgestrel-releasing IUD does not seem to be reduced in women taking enzyme-inducing drugs.
- Pregnancy: contraindicated.
- Breast-feeding: no contra-indication.
- Fertility returns rapidly after removal.
- The IUD may be inserted within 48 hours after childbirth or, after that, insertion should be delayed until after 28 days postpartum.
- Read the manufacturer's instructions for insertion and removal.
Source
MSF Essential drugs practical guidelines (January 2026)
This page combines source-derived medicine reference sections with Kenza editorial context, while leaving out the Storage and Remarks sections from the source batch.
Rate this guide
Be the first to rate this guide.
